June Lee

Last updated
June H. Lee, M.D.
Alma mater Johns Hopkins University, University of California, Davis
Scientific career
Institutions Genentech, MyoKardia, [1] UCSF, Foresite Labs [2]

June Lee is an adjunct professor in the UCSF School of Medicine, biotech executive, and medical doctor with expertise in pulmonary, critical care medicine and translational research.

Contents

Background

June Lee was born in Seoul, South Korea, and immigrated to United States at age 10. June, her two brothers, and her parents settled in southern California.

She graduated from John F. Kennedy High School in Granada Hills. She developed interest in medicine and science early in part due to a familial hereditary condition. [3] She received her undergraduate degree in chemistry at Johns Hopkins University in 1988, and earned her medical degree at the University of California, Davis in 1992. She performed residency in internal medicine at UCLA and fellowship in pulmonary and critical medicine at UCSF. [4]

Career

Hospital work

Lee served as the medical director of the High-Risk Asthma Clinic at San Francisco General Hospital. [5] She maintained an independent research program prior to Genentech, funded by the American Lung Association, to investigate IL-13 induced transcription, [6] among other pulmonary treatments.

Genentech

Lee joined the clinical development organization at Genentech initially to help launch a new biologic treatment for asthma (the data from a large respiratory study – TENOR – that resulted in multiple insights into risk factors and demographics for asthma sufferers). [7]

UCSF

Lee holds a professorship at UCSF in the School of Medicine. [8] She was the director of Early Translational Research at UCSF. [9] From 2011 to 2017, Lee served as the director of the Catalyst Program inside UCSF, which served as an internal incubator for entrepreneurial ideas from faculty, in addition to providing de-risking outsourcing partnerships and educational modules for graduate students. [10]

MyoKardia

Lee served as the chief operating officer and chief development officer for MyoKardia. [1] Myokardia was acquired by Bristol Myers Squibb for $13.1 billion in November 2020. [11]

Esker Therapeutics

June was the President and Founding CEO of Esker Therapeutics. [12]

Other

She is a member of the board of directors [13] for Novus Therapeutics, [14] GenEdit [15] and serves on the scientific advisory board for Foresite Labs [16] and Aer Therapeutics. She also serves on the advisory board for the Johns Hopkins University Center for Therapeutic Translation.

Public service

Lee has been a volunteer member of the Council of Korean Americans since 2013, and currently sits on its board of directors and previously served as chair of the board. [17] She has served previously as chair of the Drug, Device, Discovery, and Development Workgroup of UC BRAID (University of California Biomedical Research Acceleration Integration and Development). [5]

Lee is a fellow of the American College of Chest Physicians.

Related Research Articles

<span class="mw-page-title-main">University of California, San Francisco</span> Public university in California, US

The University of California, San Francisco (UCSF) is a public land-grant research university in San Francisco, California. It is part of the University of California system and is dedicated entirely to health science and life science. It conducts research and teaching in medical and biological sciences.

<span class="mw-page-title-main">Bristol Myers Squibb</span> American pharmaceutical company

The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.

<span class="mw-page-title-main">Pulmonology</span> Study of respiratory diseases

Pulmonology, pneumology or pneumonology is a medical specialty that deals with diseases involving the respiratory tract. It is also known as respirology, respiratory medicine, or chest medicine in some countries and areas.

Stephen E. Epstein is the Head of Translational and Vascular Biology Research at the MedStar Heart and Vascular Institute, MedStar Washington Hospital Center and Clinical Professor of Medicine at the Georgetown University School of Medicine.

<span class="mw-page-title-main">Respiratory disease</span> Disease of the respiratory system

Respiratory diseases, or lung diseases, are pathological conditions affecting the organs and tissues that make gas exchange difficult in air-breathing animals. They include conditions of the respiratory tract including the trachea, bronchi, bronchioles, alveoli, pleurae, pleural cavity, the nerves and muscles of respiration. Respiratory diseases range from mild and self-limiting, such as the common cold, influenza, and pharyngitis to life-threatening diseases such as bacterial pneumonia, pulmonary embolism, tuberculosis, acute asthma, lung cancer, and severe acute respiratory syndromes, such as COVID-19. Respiratory diseases can be classified in many different ways, including by the organ or tissue involved, by the type and pattern of associated signs and symptoms, or by the cause of the disease.

Janet Howard Darbyshire, CBE FMedSci is a British epidemiologist and science administrator.

Dennis Joseph Slamon, is an American oncologist and chief of the division of Hematology-Oncology at UCLA. He is best known for his work identifying the HER2/neu oncogene that is amplified in 25–33% of breast cancer patients and the resulting treatment trastuzumab.

<span class="mw-page-title-main">Sue Desmond-Hellmann</span> American oncologist, academic, and nonprofit administrator (born 1958)

Sue Desmond-Hellmann is an American oncologist and biotechnology leader who served as the Chief Executive Officer of the Bill & Melinda Gates Foundation from 2014 to 2020. In March 2024 she was elected as a board member of OpenAI. She was previously Chancellor of the University of California, San Francisco (UCSF), the first woman to hold the position, and Arthur and Toni Rembe Rock Distinguished Professor, and before that president of product development at Genentech, where she played a role in the development of the first gene-targeted cancer drugs, Avastin and Herceptin.

The National Center for Advancing Translational Sciences (NCATS) was established on December 23, 2011 and is located in Bethesda, Maryland. NCATS is one of 27 institutes and centers of the U.S. National Institutes of Health (NIH), an agency of the U.S. Department of Health and Human Services. The mission of NCATS is to transform scientific discoveries into new treatments and cures for disease that can be delivered faster to patients. The budget provided to NCATS for fiscal year 2018 is $557,373,000.

<span class="mw-page-title-main">United Therapeutics</span> American biotech company based in Maryland

United Therapeutics Corporation is an American publicly traded biotechnology company and public benefit corporation listed on the NASDAQ under the symbol UTHR. It develops novel, life-extending technologies for patients in the areas of lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire.

Ravi Kalhan is the director of the Asthma and COPD Program at Northwestern University Feinberg School of Medicine and Northwestern Memorial Hospital.

Edith A. Pérez is a Puerto Rican hematologist-oncologist. She is the Serene M. and Frances C. Durling Professor of Medicine at the Mayo Clinic Alix School of Medicine.

Raman Viswanathan was an Indian chest physician, medical mycologist and pulmonologist, considered by many as the father of Chest Medicine in India. He was the founder director of Vallabhbhai Patel Chest Institute, a postgraduate medical institute based in Delhi. An elected fellow of the American College of Chest Physicians, Royal College of Physicians of London, Indian National Science Academy and the Academy of Medical Sciences, United Kingdom, he was a recipient of several honors including the Forlanini Medal by Italian Tuberculosis Association and the Eugeno Morelli Prize of the National Academy of Sciences, Italy. The Government of India awarded him the third highest civilian honour of the Padma Bhushan, in 1974, for his contributions to medicine.

Foresite Capital (Foresite) is an American, multi-stage healthcare and life sciences investment firm headquartered in Los Angeles, and with offices in the The San Francisco Bay Area and New York City. As of June 2024, the company had raised six primary funds: Foresite Capital Fund I, II, III, IV, V and VI.

Anurag Agrawal is an Indian pulmonologist, medical researcher, Dean of the Trivedi School of Biosciences at Ashoka University, and the former director of the Institute of Genomics and Integrative Biology, a CSIR institution. Known for his studies on lung diseases, Agrawal has been a senior fellow of the DBT-Wellcome Trust. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards for his contributions to Medical Sciences in 2014. He is also a recipient of the National Bioscience Award for Career Development of the Department of Biotechnology which he received in 2015 and the 2020 Sun Pharma Science Foundation award in Medical Sciences.

<span class="mw-page-title-main">Christine Seidman</span>

Christine Edry Seidman is the Thomas W. Smith Professor of Medicine at Harvard Medical School and director of the Cardiovascular Genetics Center at Brigham and Women's Hospital. She operates a joint lab with her husband, Jonathan Seidman, where they study genetic mechanisms of heart disease. In recognition of her scientific contributions, she was elected as a fellow of the National Academy of Sciences, American Academy of Arts and Sciences, and National Academy of Medicine. In 2024, she was elected to the American Philosophical Society.

Esteban González Burchard is an American physician-scientist, a UCSF Distinguished, Endowed, Tenured Professor of Pharmacy and Medicine, Pulmonary & Critical Care Physician-Scientist trained in Genetics, Immunology, Epidemiology, Pharmacogenetics, and clinical phase 1 trials. A specialist in gene-environment interactions in asthma and health disparities.

Tina Vivienne Hartert is an American physician and the Lulu H. Owen Endowed Chair in Medicine at Vanderbilt University. She serves as Assistant Vice Chancellor for Translational Science and Director of the Center for Asthma Research. Her research considers asthma and allergic disease. During the COVID-19 pandemic Hartert studied the transmission of coronavirus disease amongst children.

Monica Kraft is an American scientist, medical professor and researcher. She is the System Chair of the Department of Medicine at the Icahn School of Medicine at Mount Sinai and Mount Sinai Health System. She is also the Murray M. Rosenberg Professor of Medicine.

Michelle R. Arkin is an American chemical biologist who is the Thomas William and Frederick John MacWilliam Distinguished Professor at the University of California, San Francisco (UCSF).

References

  1. 1 2 https://myokardia.com/
  2. ↑ "Homepage". Foresite Labs.
  3. ↑ "10 industry executives share their career paths and lessons learned". MM&M - Medical Marketing and Media. 2018-10-02. Retrieved 2018-12-05.
  4. ↑ "MyoKardia". www.myokardia.com. Retrieved 2018-12-05.
  5. 1 2 "June H. Lee, M.D." California Life Sciences Association. 2014-03-27. Archived from the original on 2018-12-05. Retrieved 2018-12-05.
  6. ↑ Lee, June H.; Kaminski, Naftali; Dolganov, Gregory; Grunig, Gabriele; Koth, Laura; Solomon, Colin; Erle, David J.; Sheppard, Dean (2001). "Interleukin-13 Induces Dramatically Different Transcriptional Programs in Three Human Airway Cell Types". American Journal of Respiratory Cell and Molecular Biology. 25 (4): 474–485. doi:10.1165/ajrcmb.25.4.4522. PMID   11694453.
  7. ↑ Wenzel, Sally E.; Chipps, Bradley E.; Rasouliyan, Lawrence; Borish, Larry; Haselkorn, Tmirah; Lee, June H. (2007-12-01). "Risk Factors Associated With Persistent Airflow Limitation in Severe or Difficult-to-Treat Asthma: Insights From the TENOR Study". Chest. 132 (6): 1882–1889. doi:10.1378/chest.07-0713. ISSN   0012-3692. PMID   18079222.
  8. ↑ "June Lee | UCSF Profiles". profiles.ucsf.edu. Retrieved 2018-12-05.
  9. ↑ "CTSI Research Award Helps Move Promise to Product at UCSF". UC San Francisco. 19 September 2011. Retrieved 2018-12-05.
  10. ↑ "Q&A with Catalyst Director June Lee, MD". Clinical & Translational Science Institute. Retrieved 2018-12-05.
  11. ↑ "Bristol Myers Squibb to Acquire MyoKardia for $13.1 Billion in Cash".
  12. ↑ "Esker Therapeutics Launches to Transform the Treatment of Autoimmune Diseases" (Press release). 5 May 2021.
  13. ↑ "Novus Therapeutics Appoints June Lee, M.D., to Board of Directors". 9 December 2020.
  14. ↑ "Home - Eledon Pharmaceuticals, Inc".
  15. ↑ "About | GenEdit". 19 August 2021.
  16. ↑ "Foresite Labs".
  17. ↑ "June Lee". Council Korean Americans. Archived from the original on 2018-12-05. Retrieved 2018-12-05.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.